Clinical Trial Update: Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of ofatumumab and bendamustine in patients with previously treated chronic lymphocytic leukemia and small lymphocytic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• Ofatumumab (ofatumumab)

Snippet

Sponsor: Georgetown University | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2015-12-15